Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of human papillomavirus type 35/hpv35 type l1/l2 and its preparation and application

A technology of human papillomavirus and pseudovirus, which is applied in the biological field to achieve the effects of simple interpretation, short detection cycle and good repeatability

Active Publication Date: 2022-02-22
上海博唯生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In view of the above-mentioned shortcoming of the prior art, the object of the present invention is to provide a gene sequence of the human papillomavirus type 35 L1 / L2 protein, which is used to solve the problem of HPV type 35 pseudovirus preparation and pseudovirus in HPV in the prior art. Application of Neutralizing Antibody Titer in Type 35 Samples

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of human papillomavirus type 35/hpv35 type l1/l2 and its preparation and application
  • A kind of human papillomavirus type 35/hpv35 type l1/l2 and its preparation and application
  • A kind of human papillomavirus type 35/hpv35 type l1/l2 and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 Optimization of HPV 35L1 protein and HPV 35L2 protein coding gene

[0027] The genes encoding HPV 35L1 protein and HPV35L2 protein were optimized based on multiple dimensions such as codon usage frequency, RNA secondary structure, and GC content. The amino acid sequence of HPV 35L1 protein is shown in SEQ ID NO.1 (GenBank accession number: CAA52566.1), and the amino acid sequence of HPV 35L2 protein is shown in SEQ ID NO.2 (GenBank accession number: CAA52565.1). The gene encoding the HPV 35L1 protein before optimization is SEQ ID NO.3, and the gene encoding the HPV 35L1 protein after optimization is SEQ ID NO.4 (HPV 35L1-op1) and SEQ ID NO.5 (HPV 35L1-op2). The gene encoding the HPV35L2 protein before optimization is SEQ ID NO.6, and the gene encoding the HPV 35L2 protein after optimization is SEQ ID NO.7 (HPV 35L2-op1) and SEQ ID NO.8 (HPV 35L2-op2).

[0028] SEQ ID NO.1 (amino acid sequence of HPV 35L1 protein)

[0029]MSLWRSNEATVYLPPVSVSKVVSTDEYVTRTNIYYHA...

Embodiment 2

[0044] Construction and preparation of embodiment 2 HPV 35 type pseudoviruses

[0045] Step 1: Insert HPV 35L1, HPV 35L1-op1, HPV 35L1-op2, HPV 35L2, HPV 35L2-op1, HPV35L2-op2, and EGFP (fluorescent protein reporter) genes into pCDNA3.1 plasmids to obtain expression plasmids 35L1-pCDNA3, respectively .1 (SEQ ID NO.9), 35L1-op1-pCDNA3.1 (SEQ ID NO.10), 35L1-op2-pCDNA3.1 (SEQ ID NO.11), 35L2-pCDNA3.1 (SEQ ID NO.12 ), 35L2-op1-pCDNA3.1 (SEQ ID NO.13), 35L2-op2-pCDNA3.1 (SEQ ID NO.14), EGFP-pCDNA3.1 (SEQ ID NO.15).

[0046] Expression plasmid 35L1-pCDNA3.1 sequence (including pre-optimized gene HPV 35L1), SEQ ID NO.9:

[0047]GACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTGATG CCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCG CGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTG CTTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTTGACAT TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATAT GGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAA...

Embodiment 3

[0069] Example 3 Application of Enzyme-Linked Fluorescent Spot Analyzer to Detect HPV Type 35 Pseudovirus Using Multiples

[0070] Step 1: Collect 293FT cells in the logarithmic growth phase, count with a hemocytometer and dilute the cells with DMEM complete medium to a density of 1.5×10 5 pieces / ml.

[0071] Step 2: In a 96-well cell culture plate, add 150 μl of 293FT cells per well, place at 37°C, 5% CO 2 Cultivate in an incubator for 16-24 hours.

[0072] Step 3: Take the pseudovirus solution and dilute it with DMEM complete medium to 200 times or an appropriate multiple, then dilute according to the 2-fold ratio, and serially dilute 4 to 8 dilutions.

[0073] Step 4: Add 50 μl pseudovirus dilution solution to each well, set 8 wells to repeat for each dilution, and set a blank control at the same time, the blank control is 50 μl DMEM complete medium, after culturing for 72 hours, use an enzyme-linked fluorescence spot analyzer to detect each well of green fluorescent dot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a kind of human papillomavirus type 35 / HPV35 type L1 / L2 and its preparation and application. The applicant has optimized the coding genes of the L1 protein and L2 protein in the pseudovirus, so that when the pseudovirus is used, The dilution factor is significantly improved, and the detection period is short, the sensitivity is high, the repeatability is good, the result interpretation is simple, the detection cost is low, and the method is convenient for application and promotion.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a human papillomavirus type 35 / HPV35 type L1 / L2 and its preparation and application. Background technique [0002] Cervical cancer and cervical precancers are a major problem in women's health worldwide. Clinical, molecular biology, and epidemiological investigations have proved that human papillomavirus (human papillomavirus, HPV) is the main cause of cervical cancer and cervical dysplasia. At present, more than 200 subtypes of HPV have been found, which are divided into high-risk types according to different pathogenicity, including HPV16, 18, 31, 33, 35, 39, 45, etc.; low-risk types include HPV6, 11, etc. HPV is a non-enveloped circular double-stranded DNA virus. Its capsid is an icosahedral structure composed of 72 major capsid protein L1 protein pentamers. One virion contains 360 L1 protein monomers. The World Health Organization International Agency for Research on Cancer has...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/37C12N15/85C12N15/65C12N5/10G01N33/68G01N33/569
Inventor 王丽波姬美彤潘婷傅文彬周朝明沈琼
Owner 上海博唯生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com